Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult Subjects
NCT00555451
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Insulin Resistance
Interventions
DRUG:
HE3286
Sponsor
Harbor Therapeutics